Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,607,450
-$5,078 QoQ
Shares Held
4,439
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#1,399
of 3,140 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FWL INVESTMENT MANAGEMENT, LLC holds $23,618,681 across 9 Drug Manufacturers - General names. AMGN ranks #2 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,864 | $19,027,759 | |
| 2 | AMGN |
Amgen Inc
This page
|
4,439 | $1,607,450 | |
| 3 | ABBV |
AbbVie Inc.
|
5,047 | $1,270,027 | |
| 4 | AZN |
Astrazeneca PLC
|
4,601 | $872,441 | |
| 5 | JNJ |
Johnson & Johnson
|
2,809 | $713,401 | |
| 6 | MRK |
Merck & Co., Inc.
|
866 | $111,281 | |
| 7 | NVS |
Novartis AG
|
90 | $14,104 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13 | $1,642 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,607,450 | 4,439 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,612,528 | 4,583 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,492,206 | 4,559 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,313,358 | 4,654 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,433,184 | 5,133 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,460,546 | 4,688 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,248,465 | 4,790 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,404,513 | 4,359 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $59,365 | 190 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||